Working with cells grown in the lab, Johns Hopkins researchers have identified a biochemical pathway that allows a structure within cells, called the Golgi apparatus, to combat stress caused by free radicals and oxidants. The research team showed that this pathway can be activated by a drug called monensin, which is commonly used as an antibiotic in animal feed.
The findings, they say, could help scientists develop new ways to protect cells against the type of oxidative stress linked to Huntington's disease.
Details of the pathway, which involves the response from a series of proteins, are reported in the Jan. 9 issue of the Proceedings of the National Academy of Sciences.
"Normally, elevated oxidative stress is not good for cells, as it can compromise their natural protective responses," says Bindu Paul, M.S., Ph.D., instructor of neuroscience at the Johns Hopkins University School of Medicine's Solomon H. Snyder Department of Neuroscience. "We showed that we can enhance a pathway that protects the cells with a method that resembles vaccination. By giving a lower, less potent, dose of the stressor, you can boost the cell's response so that it has a robust reaction to the real threat later on," says Juan Sbodio, Ph.D., postdoctoral fellow at Johns Hopkins University School of Medicine's Solomon H. Snyder Department of Neuroscience.
The Golgi is best known for its role as the shipping and sorting center of the cell, shuttling proteins to their proper locations. However, the ribbon-like structure is also one of the first responders to cellular stress, and it helps to protect the cell by producing cysteine, a basic building block of the proteins that make up our bodies, including the body's natural antioxidant glutathione.
When a cell is exposed to cysteine deprivation and oxidative stress, the cell sends out the alarm to produce more cysteine to create glutathione, which combats oxidative stress by binding to and neutralizing oxidating agents. The researchers knew that a similar process is initiated by the Golgi when exposed to monensin to induce Golgi stress and wanted to explore this response further.
To better understand the effects of the drug, the scientists bathed cells in low doses of monensin, which, at high doses, is known to break apart Golgi. The researchers found that after the treatment, the proteins PERK, ATF4 and cystathionine ?-lyase (CSE) -- the protein that is activated to create cysteine -- appeared in elevated levels within the cell compared to nontreated cells. Previous research has linked low CSE production to Huntington's disease. Because of this, researchers believe that neurons with Huntington's disease cannot counteract dangerous free radicals or oxidants and are at risk of dying from stress.
The researchers wanted to find if there was a way to increase cysteine production in afflicted cells to protect them. The researchers gave lab-grown mouse cells that mimicked human Huntington's disease a small dose of monensin and depleted cysteine in their nutrient bath.
The cells treated with monensin grew normally for 7-9 days during the experiment, while those not treated with monensin withered away, the team reports.
"We think that the monensin treatment built up the cell's reserve of CSE and cysteine, protecting the cells against low cysteine levels," says Paul.
The researchers also found that this stress response pathway also kick starts another pathway that creates hydrogen sulfide, a gas and key regulator for many important cellular processes.
In the future, the researchers hope to further study the pathway's role in overall cellular health.
Other researchers involved in this study include Solomon H. Snyder of the Johns Hopkins University School of Medicine Solomon H. Snyder Department of Neuroscience.
Funding for this research was provided by the U.S. Public Health Service (MH18501) and the CHDI Foundation.
Rachel Butch | EurekAlert!
Sugar entering the brain during septic shock causes memory loss
23.04.2019 | Rensselaer Polytechnic Institute
Deep stimulation improves cognitive control by augmenting brain rhythms
04.04.2019 | Picower Institute at MIT
Researchers led by Francesca Ferlaino from the University of Innsbruck and the Austrian Academy of Sciences report in Physical Review X on the observation of supersolid behavior in dipolar quantum gases of erbium and dysprosium. In the dysprosium gas these properties are unprecedentedly long-lived. This sets the stage for future investigations into the nature of this exotic phase of matter.
Supersolidity is a paradoxical state where the matter is both crystallized and superfluid. Predicted 50 years ago, such a counter-intuitive phase, featuring...
A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter
A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.
Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...
The technology could revolutionize how information travels through data centers and artificial intelligence networks
Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...
Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.
Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...
17.04.2019 | Event News
15.04.2019 | Event News
09.04.2019 | Event News
24.04.2019 | Trade Fair News
23.04.2019 | Information Technology
23.04.2019 | Earth Sciences